Intestinal insufficiency and failure

Danish Medical Bulletin

Volumn 50, Issue 3, 2003, Pages 238-261

  Jeppesen, Palle Bekker ^a,b  

^a Rigshospitalet   (Denmark)

^b NONE   (Denmark)

Author keywords

[No Author keywords available]

Indexed keywords

CIMETIDINE; CODEINE PHOSPHATE; GASTROINTESTINAL HORMONE; GLUCAGON LIKE PEPTIDE 2; GLUTAMINE; GROWTH HORMONE; LOPERAMIDE; OCTREOTIDE; OMEPRAZOLE; RANITIDINE;

CARBOHYDRATE DIET; CLINICAL TRIAL; DOSE RESPONSE; DRUG ACTIVITY; DRUG EFFECT; HUMAN; INTESTINE ABSORPTION; INTESTINE FUNCTION; INTESTINE MOTILITY; INTESTINE RESECTION; PARENTERAL NUTRITION; PATHOPHYSIOLOGY; REVIEW; SHORT BOWEL SYNDROME; STOMACH EMPTYING; STOMACH SECRETION;

ADAPTATION, PHYSIOLOGICAL; GASTROINTESTINAL MOTILITY; HUMANS; INTESTINAL ABSORPTION; NUTRITION THERAPY; QUALITY OF LIFE; SHORT BOWEL SYNDROME;

EID: 0042822148     PISSN: 09078916     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Review

References (295)

1. Bryant J. Observations upon the growth and length of the human intestine. Am J Med Sci 1924; 167: 499-520.
2. Hirsch J, Ahrens EH, Blankenhorn DH. Measurement of the human intestinal length in vivo and some causes of variation. Gastroenterology 1956; 31: 274-284.
3. Fanucci A, Cerro P, Fraracci L, Ietto F. Small bowel length measured by radiography. Gastrointest Radiol 1984; 9: 349-351.
4. Nightingale JM, Bartram CI, Lennard Jones JE. Length of residual small bowel after partial resection: correlation between radiographic and surgical measurements. Gastrointest Radiol 1991; 16: 305-306.
5. Carbonnel F, Cosnes J, Chevret S, et al. The role of anatomic factors in nutritional autonomy after extensive small bowel resection. JPEN J Parenter Enteral Nutr 1996; 20: 275-280.
6. Nightingale JM, Lennard Jones JE, Walker ER, Farthing MJ. Jejunal efflux in short bowel syndrome [see comments]. Lancet 1990; 336: 765-768.
7. Nightingale JM, Lennard Jones JE, Gertner DJ, Wood SR, Bartram CI. Colonic preservation reduces need for parenteral therapy, increases incidence of renal stones, but does not change high prevalence of gall stones in patients with a short bowel. Gut 1992; 33: 1493-1497.
8. Messing B, Crenn P, Beau P, Boutron Ruault MC, Rambaud JC, Matuchansky C. Long-term survival and parenteral nutrition dependence in adult patients with the short bowel syndrome. Gastroenterology 1999; 117: 1043-1050.
9. Nordgaard I, Hansen BS, Mortensen PB. Importance of colonic support for energy absorption as small-bowel failure proceeds. Am J Clin Nutr 1996; 64: 222-231.
10. Fordtran JS, Locklear TW. Ionic constituents and osmolality of gastric and small-intestinal fluids after eating. Am J Dig Dis 1966; 11: 503-521.
11. Borgström B, Dahlqvist A, Lundh G, Sjövall J. Studies of intestinal digestion and absorption in the human. J Clin Invest 1957; 36: 1521-1536.
12. Booth CC. The metabolic effects of intestinal resection in man. Postgrad Med J 1961; 37: 725-739.
13. Hofmann AF, Poley JR. Role of bile acid malabsorption in pathogenesis of diarrhea and steatorrhea in patients with ileal resection. I. Response to cholestyramine or replacement of dietary long chain triglyceride by medium chain triglyceride. Gastroenterology 1972; 62: 918-934.
14. Hofmann AF, Poley JR. Cholestyramine treatment of diarrhea associated with ileal resection. N Engl J Med 1969; 281: 397-402.
15. Ammon HV, Phillips SF. Inhibition of colonic water and electrolyte absorption by fatty acids in man. Gastroenterology 1973; 65: 744-749.
16. Hofmann AF, Danzinger RG. Physiologic and clinical significance of ileal resection. Surg Annu 1972; 4: 305-325.
17. McNeil NI. The contribution of the large intestine to energy supplies in man. Am J Clin Nutr 1984; 39: 338-342.
18. Nordgaard I, Hansen BS, Mortensen PB. Colon as a digestive organ in patients with short bowel [see comments]. Lancet 1994; 343: 373-376.
19. Mortensen PB. The effect of oral-administered lactulose on colonic nitrogen metabolism and excretion. Hepatology 1992; 16: 1350-1356.
20. Chacko A, Cummings JH. Nitrogen losses from the human small bowel: obligatory losses and the effect of physical form of food. Gut 1988; 29: 809-815.
21. Chadwick VS, Phillips SF, Hofmann AF. Measurements of intestinal permeability using low molecular weight polyethylene glycols (PEG 400). II. Application to normal and abnormal permeability states in man and animals. Gastroenterology 1977; 73: 247-251.
22. Davis GR, Santa Ana CA, Morawski SG, Fordtran JS. Permeability characteristics of human jejunum, ileum, proximal colon and distal colon: results of potential difference measurements and unidirectional fluxes. Gastroenterology 1982; 83: 844-850.
23. Fordtran JS, Rector FC, Jr., Carter NW. The mechanisms of sodium absorption in the human small intestine. J Clin Invest 1968; 47: 884-900.
24. Spiller RC, Jones BJ, Silk DB. Jejunal water and electrolyte absorption from two proprietary enteral feeds in man: importance of sodium content. Gut 1987; 28: 681-687.
25. Griffin GE, Fagan EF, Hodgson HJ, Chadwick VS. Enteral therapy in the management of massive gut resection complicated by chronic fluid and electrolyte depletion. Dig Dis Sci 1982; 27: 902-908.
26. Ladefoged K, Olgaard K. Fluid and electrolyte absorption and renin-angiotensin-aldosterone axis in patients with severe short-bowel syndrome. Scand J Gastroenterol 1979; 14: 729-735.
27. Dudrick SJ, Latifi R, Fosnocht DE. Management of the short-bowel syndrome. Surg Clin North Am 1991; 71: 625-643.
28. Ganong WF. Gastrointestinal secretions and motility. In: Review of medical physiology. 11th ed. Los Altos: Lange Medical Publications, 1983: 387-413.
29. Debongnie JC, Phillips SF. Capacity of the human colon to absorb fluid. Gastroenterology 1978; 74: 698-703.
30. Binder HJ. Editorial: Fecal fatty acids-mediators of diarrhea? Gastroenterology 1973; 65: 847-850.
31. Ammon HV, Phillips SF. Inhibition of ileal water absorption by intraluminal fatty acids. Influence of chain length, hydroxylation, and conjugation of fatty acids. J Clin Invest 1974; 53: 205-210.
32. James AT, Webb JPW. The occurrence of unususal fatty acids in faecal lipids from human beings with normal and abnormal fat absorption. Biochem J 1961; 333-339.
33. Spiller RC, Brown ML, Phillips SF. Decreased fluid tolerance, accelerated transit, and abnormal motility of the human colon induced by oleic acid. Gastroenterology 1986; 91: 100-107.
34. Spiller RC. Feedforward and feedback control mechanisms in the gut. With special emphasis on inhibitory feedback by nutrients in the distal small bowel and colon. Dig Dis 1990; 8: 189-205.
35. Osborne MP, Frederick PL, Sizer JS, Blair D, Cole P, Thum W. Mechanism of gastric hypersecretion following massive intestinal resection. Clinical and experimental observations. Ann Surg 1966; 164: 622-634.
36. Frederick PL, Sizer JS, Osborne MP. Relation of massive bowel resection to gastric secretion. N Engl J Med 1965; 272: 509-514.
37. Winawer SJ, Broitman SA, Wolochow DA, Osborne MP, Zamcheck N. Successful management of massive small-bowel resection based on assessment of absorption defects and nutritional needs. New Engl J Med 1966; 274: 72-78.
38. Windsor CW, Fejfar J, Woodward DA. Gastric secretion after massive small bowel resection. Gut 1969; 10: 779-786.
39. Wickbom G, Landor JH, Bushkin FL, McGuigan JE. Changes in canine gastric acid output and serum gastrin levels following massive small intestinal resection. Gastroenterology 1975; 69: 448-452.
40. Fielding JF, Cooke WT, Williams JA. Gastric acid secretion in Crohn's disease in relation to disease activity and bowel resection. Lancet 1971; 1: 1106-1107.
41. Williams NS, Evans P, King RF. Gastric acid secretion and gastrin production in the short bowel syndrome. Gut 1985; 26: 914-919.
42. Murphy JP, Jr., King DR, Dubois A. Treatment of gastric hypersecretion with cimetidine in the short-bowel syndrome. N Engl J Med 1979; 300: 80-81.
43. Salmon PA, Wright WJ. Effect of small-bowel bypass on gastric secretion in obese patients. Can J Surg 1968; 11: 365-368.
44. Adrian TE, Savage AP, Sagor GR, et al. Effect of peptide YY on gastric, pancreatic, and biliary function in humans. Gastroenterology 1985; 89: 494-499.
45. Layer P, Holst JJ, Grandt D, Goebell H. Ileal release of glucagon-like peptide-1 (GLP-1). Association with inhibition of gastric acid secretion in humans. Dig Dis Sci 1995; 40: 1074-1082.
46. Wettergren A, Maina P, Boesby S, Holst JJ. Glucagon-like peptide-1 7-36 amide and peptide YY have additive inhibitory effect on gastric acid secretion in man. Scand J Gastroenterol 1997; 32: 552-555.
47. Wojdemann M, Wettergren A, Hartmann B, Hilsted L, Holst JJ. Inhibition of sham feeding-stimulated human gastric acid secretion by glucagon-like peptide-2. J Clin Endocrinol Metab 1999; 84: 2513-2517.
48. Heizer WD, Cleveland CR, Iber FL. Gastric inactivation of pancreatic supplements. Bull Johns Hopkins Hosp 1965; 116: 261-265.
49. Malagelada JR. Pathophysiological responses to meals in the Zollinger-Ellison syndrome: 2. Gastric emptying and its effect on duodenal function. Gut 1980; 21: 98-104.
50. Go VL, Poley JR, Hofmann AF, Summerskill WH. Disturbances in fat digestion induced by acidic jejunal pH due to gastric hypersecretion in man. Gastroenterology 1970; 58: 638-646.
51. Nightingale JM, Kamm MA, van der Sijp JR, et al. Disturbed gastric emptying in the short bowel syndrome. Evidence for a "colonic brake". Gut 1993; 34: 1171-1176.
52. Wojdemann M, Wettergren A, Hartmann B, Holst JJ. Glucagon-like peptide-2 inhibits centrally induced antral motility in pigs. Scand J Gastroenterol 1998; 33: 828-832.
53. Nauck MA, Niedereichholz U, Ettler R, et al. Glucagon-like peptide 1 inhibition of gastric emptying outweighs its insulinotropic effects in healthy humans. Am J Physiol 1997; 273: E981-988.
54. Forrester JM. The number of villi in rat's jejunum and ileum: effect of normal growth, partial enterectomy, and tube feeding. J Anat 1972; 111: 283-291.
55. Friedman HI, Chandler JG, Peck CC, Nemeth TJ, Odum SK. Alterations in intestinal structure, fat absorption and body weight after intestinal bypass for morbid obesity. Surg Gynecol Obstet 1978; 146: 757-767.
56. Eastwood GL. Gastrointestinal epithelial renewal. Gastroenterology 1977; 72: 962-975.
57. Dowling RH, Booth CC. Structural and functional changes following small intestinal resection in the rat. Clin Sci 1967; 32: 139-149.
58. Obertop H, Nundy S, Malamud D, Malt RA. Onset of cell proliferation in the shortened gut. Rapid hyperplasia after jejunal resection. Gastroenterology 1977; 72: 267-270.
59. Nygaard K. Resection of the small intestine in rats. 3. Morphological changes in the intestinal tract. Acta Chir Scand 1967; 133: 233-248.
60. Booth CC, Evans KT, Menzies T, Street DF. Intestinal hypertrophy following partial resection of the small bowel in the rat. Br J Surg 1958; 46: 403-410.
61. Porus RL. Epithelial hyperplasia following massive small bowel resection in man. Gastroenterology 1965; 48: 753-757.
62. Hanson WR, Osborne JW, Sharp JG. Compensation by the residual intestine after intestinal resection in the rat. 1. Influence of amount of tissue removed. Gastroenterology 1977; 72: 692-700.
63. Hanson WR, Osborne JW, Sharp JG. Compensation by the residual intestine after intestinal resection in the rat. II. Influence of postoperative time interval. Gastroenterology 1977; 72: 701-705.
64. Tilson MD, Wright HK. Adaptation of functioning and bypassed segments of ileum during compensatory hypertrophy of the gut. Surgery 1970; 67: 687-693.
65. Weser E, Hernandez MH. Studies of small bowel adaptation after intestinal resection in the rat. Gastroenterology 1971; 60: 69-75.
66. Tilson MD, Michaud JT, Livstone EM. Early proliferative activity in the left colon of the rat after partial small-bowel resection. Surg Forum 1976; 27: 445-446.
67. Williamson RC, Bauer FL, Ross JS, Malt RA. Proximal enterectomy stimulates distal hyperplasia more than bypass or pancreaticobiliary diversion. Gastroenterology 1978; 74: 16-23.
68. Nundy S, Malamud D, Obertop H, Sczerban J, Malt RA. Onset of cell proliferation in the shortened gut. Colonic hyperplasia after ileal resection. Gastroenterology 1977; 72: 263-266.
69. Solhaug JH, Tvete S. Adaptative changes in the small intestine following bypass operation for obesity. A radioglocal and histological study. Scand J Gastroenterol 1978; 13: 401-408.
70. Young EA, Weser E. Nutritional adaptation after small bowel resection in rats. J Nutr 1974; 104: 994-1001.
71. Wright HK, Poskitt T, Cleveland JC, Herskovic T. The effect of total colectomy on morphology and absorptive capacity of ileum in the rat. J Surg Res 1969; 9: 301-304.
72. Woo ZH, Nygaard K. Small-bowel adaptation after colectomy in rats. Scand J Gastroenterol 1978; 13: 903-910.
73. Nightingale JM, Lennard Jones JE. The short bowel syndrome: what's new and old? Dig Dis 1993; 11: 12-31.
74. Dowling RH, Booth CC. Functional compensation after small-bowel resection in man. Demonstration by direct measurement. Lancet 1966; 2: 146-147.
75. Weinstein LD, Shoemaker CP, Hersh T, Wright HK. Enhanced intestinal absorption after small bowel resection in man. Arch Surg 1969; 99: 560-562.
76. Hill GL, Mair WS, Goligher JC. Impairment of "ileostomy adaptation" in patients after ileal resection. Gut 1974; 15: 982-987.
77. Gouttebel MC, Saint Aubert B, Colette C, Astre C, Monnier LH, Joyeux H. Intestinal adaptation in patients with short bowel syndrome. Measurement by calcium absorption. Dig Dis Sci 1989; 34: 709-715.
78. McCarthy DM, Kim YS. Changes in sucrase, enterokinase, and peptide hydrolase after intestinal resection. The association of cellular hyperplasia and adaptation. J Clin Invest 1973; 52: 942-951.
79. Tilson MD, Wright HK. An adaptive change in ileal Na-K-ATPase activity after jejunectomy or jejunal transposition. Surgery 1971; 70: 421-424.
80. Remington M, Malagelada JR, Zinsmeister A, Fleming CR. Abnormalities in gastrointestinal motor activity in patients with short bowels: effect of a synthetic opiate. Gastroenterology 1983; 85: 629-636.
81. Williamson RC. Intestinal adaptation (second of two parts). Mechanisms of control. N Engl J Med 1978; 298: 1444-1450.
82. Weser E, Heller R, Tawil T. Stimulation of mucosal growth in the rat ileum by bile and pancreatic secretions after jejunal resection. Gastroenterology 1977; 73: 524-529.
83. Altmann GG. Influence of bile and pancreatic secretions on the size of the intestinal villi in the rat. Am J Anat 1971; 132: 167-177.
84. Miazza BM, Levan H, Veja S, Dowling RH. Effect of pancreatico-bilary diversion (PBD) on jejunal and ileal structure and function in the rat. In: Robinson JW, Dowling RH, Riecken EO, eds. Mechanisms of intestinal adaptation. Falk symposium 30 ed. Lancaster: MTP Press Limited, 1982: 467-476.
85. Weser E, Drummond A, Tawil T. Effect of diverting bile and pancreatic secretions into the ileum on small bowel mucosa in rats fed a liquid formula diet. JPEN J Parenter Enteral Nutr 1982; 6: 39-42.
86. Gelinas MD, Morin CL. Effects of bile and pancreatic secretions on intestinal mucosa after proximal small bowel resection in rats. Can J Physiol Pharmacol 1980; 58: 1117-1123.
87. Ford WD, Boelhouwer RU, King WW, de Vries JE, Ross JS, Malt RA. Total parenteral nutrition inhibits intestinal adaptive hyperplasia in young rats: reversal by feeding. Surgery 1984; 96: 527-534.
88. Feldman EJ, Dowling RH, McNaughton J, Peters TJ. Effects of oral versus intravenous nutrition on intestinal adaptation after small bowel resection in the dog. Gastroenterology 1976; 70: 712-719.
89. Levine GM, Deren JJ, Yezdimir E. Small-bowel resection. Oral intake is the stimulus for hyperplasia. Am J Dig Dis 1976; 21: 542-546.
90. Buchman AL, Moukarzel AA, Bhuta S, et al. Parenteral nutrition is associated with intestinal morphologic and functional changes in humans. JPEN J Parenter Enteral Nutr 1995; 19: 453-460.
91. Guedon C, Schmitz J, Lerebours E, et al. Decreased brush border hydrolase activities without gross morphologic changes in human intestinal mucosa after prolonged total parenteral nutrition of adults. Gastroenterology 1986; 90: 373-378.
92. Hughes CA, Dowling RH. Speed of onset of adaptive mucosal hypoplasia and hypofunction in the intestine of parenterally fed rats. Clin Sci 1980; 59: 317-327.
93. Buts JP, Morin CL, Ling V. Influence of dietary components on intestinal adaptation after small bowel resection in rats. Clin Invest Med 1979; 2: 59-66.
94. Lai HS, Chen WJ, Chen KM, Lee YN. Effects of monomeric and polymeric diets on small intestine following massive resection. Taiwan I Hsueh Hui Tsa Chih 1989; 88: 982-988.
95. Morin CL, Grey VL, Garafalo C. Influence of lipids on intestinal adaptation after resection. In: Robinson JW, Dowling RH, Riecken EO, eds. Mechanisms of intestinal adaptation. Lancaster: MTP Press Limited, 1982: 175-185.
96. Spector MH, Levine GM, Deren JJ. Direct and indirect effects of dextrose and amino acids on gut mass. Gastroenterology 1977; 72: 706-710.
97. Spector MH, Traylor J, Young EA, Weser E. Stimulation of mucosal growth by gastric and ileal infusion of single amino acids in parenterally nourished rats. Digestion 1981; 21: 33-40.
98. Weser E, Vandeventer A, Tawil T. Stimulation of small bowel mucosal growth by midgut infusion of different sugars in rats maintained by total parenteral nutrition. J Pediatr Gastroenterol Nutr 1982; 1: 411-416.
99. Weser E, Vandeventer A, Tawil T. Non-hormonal regulation of intestinal adaptation. Scand J Gastroenterol 1982; 17: 105-113.
100. Vanderhoof JA, Park JH, Herrington MK, Adrian TE. Effects of dietary menhaden oil on mucosal adaptation after small bowel resection in rats. Gastroenterology 1994; 106: 94-99.
101. Park JH, Grandjean CJ, Hart MH, Baylor JM, Vanderhoof JA. Effects of dietary linoleic acid on mucosal adaptation after small bowel resection. Digestion 1989; 44: 57-65.
102. Hart MH, Grandjean CJ, Park JH, Erdman SH, Vanderhoof JA. Essential fatty acid deficiency and postresection mucosal adaptation in the rat. Gastroenterology 1988; 94: 682-687.
103. Vanderhoof JA, Grandjean CJ, Kaufman SS, Burkley KT, Antonson DL. Effect of high percentage medium-chain triglyceride diet on mucosal adaptation following massive bowel resection in rats. JPEN J Parenter Enteral Nutr 1984; 8: 685-689.
104. Kripke SA, De Paula JA, Berman JM, Fox AD, Rombeau JL, Settle RG. Experimental short-bowel syndrome: effect of an elemental diet supplemented with short-chain triglycerides. Am J Clin Nutr 1991; 53: 954-962.
105. Kripke SA, Fox AD, Berman JM, Settle RG, Rombeau JL. Stimulation of intestinal mucosal growth with intracolonic infusion of short-chain fatty acids. JPEN J Parenter Enteral Nutr 1989; 13: 109-116.
106. Frankel WL, Zhang W, Singh A, et al. Mediation of the trophic effects of short-chain fatty acids on the rat jejunum and colon. Gastroenterology 1994; 375-380.
107. Windmueller HG, Spaeth AE. Identification of ketone bodies and glutamine as the major respiratory fuels in vivo for postabsorptive rat small intestine. J Biol Chem 1978; 253: 69-76.
108. Ruppin H, Bar Meir S, Soergel KH, Wood CM, Schmitt MG, Jr. Absorption of short-chain fatty acids by the colon. Gastroenterology 1980; 78: 1500-1507.
109. Roediger WE, Moore A. Effect of short-chain fatty acid on sodium absorption in isolated human colon perfused through the vascular bed. Dig Dis Sci 1981; 26: 100-106.
110. Sakata T. Stimulatory effect of short-chain fatty acids on epithelial cell proliferation of isolated and denervated jejunal segment of the rat. Scand J Gastroenterol 1989; 24: 886-890.
111. Tappenden KA, Drozdowski LA, Thomson AB, McBurney MI. Short-chain fatty acid-supplemented total parenteral nutrition alters intestinal structure, glucose transporter 2 (GLUT2) mRNA and protein, and proglucagon mRNA abundance in normal rats. Am J Clin Nutr 1998; 68: 118-125.
112. Bloom SR, Polak JM. The hormonal pattern of intestinal adaptation. A major role for enteroglucagon. Scand J Gastroenterol Suppl 1982; 14: 93-103.
113. Sagor GR, Ghatei MA, AI Mukhtar MY, Wright NA, Bloom SR. Evidence for a humoral mechanism after small intestinal resection. Exclusion of gastrin but not enteroglucagon. Gastroenterology 1983; 84: 902-906.
114. Rountree DB, Ulshen MH, Selub S, et al. Nutrient-independent increases in proglucagon and ornithine decarboxylase messenger RNAs after jejunoileal resection. Gastroenterology 1992; 103: 462-468.
115. Taylor RG, Verity K, Fuller PJ. Ileal glucagon gene expression: ontogeny and response to massive small bowel resection. Gastroenterology 1990; 99: 724-729.
116. Rolandelli RH, Koruda MJ, Settle RG, Rombeau JL. The effect of enteral feedings supplemented with pectin on the healing of colonic anastomoses in the rat. Surgery 1986; 99: 703-707.
117. Spiller GA, Chernoff MC, Hill RA, Gates JE, Nassar JJ, Shipley EA. Effect of purified cellulose, pectin, and a low-residue diet on fecal volatile fatty acids, transit time, and fecal weight in humans. Am J Clin Nutr 1980; 33: 754-759.
118. Roth JA, Frankel WL, Zhang W, Klurfeld DM, Rombeau JL. Pectin improves colonic function in rat short bowel syndrome. J Surg Res 1995; 58: 240-246.
119. Koruda MJ, Rolandelli RH, Settle RG, Rombeau JL. Small bowel disaccharidase activity in the rat as affected by intestinal resection and pectin feeding. Am J Clin Nutr 1988; 47: 448-453.
120. Koruda MJ, Rolandelli RH, Settle RG, Saul SH, Rombeau JL. Harry M. Vats award. The effect of a pectin-supplemented elemental diet on intestinal adaptation to massive small bowel resection. JPEN J Parenter Enteral Nutr 1986; 10: 343-350.
121. Souba WW, Smith RJ, Wilmore DW. Glutamine metabolism by the intestinal tract. JPEN J Parenter Enteral Nutr 1985; 9: 608-617.
122. Tamada H, Nezu R, Matsuo Y, Imamura I, Takagi Y, Okada A. Alanyl glutamine-enriched total parenteral nutrition restores intestinal adaptation after either proximal or distal massive resection in rats. JPEN J Parenter Enteral Nutr 1993; 17: 236-242.
123. Rhoads JM, Keku EO, Quinn J, Woosely J, Lecce JG. L-glutamine stimulates jejunal sodium and chloride absorption in pig rotavirus enteritis [see comments]. Gastroenterology 1991; 100: 683-691.
124. Gardemann A, Watanabe Y, Grosse V, Hesse S, Jungermann K. Increases in intestinal glucose absorption and hepatic glucose uptake elicited by luminal but not vascular glutamine in the jointly perfused small intestine and liver of the rat. Biochem J 1992; 283: 759-765.
125. O'Dwyer ST, Smith RJ, Hwang TL, Wilmore DW. Maintenance of small bowel mucosa with glutamine-enriched parenteral nutrition. JPEN J Parenter Enteral Nutr 1989; 13: 579-585.
126. Vanderhoof JA, Blackwood DJ, Mohammadpour H, Park JH. Effects of oral supplementation of glutamine on small intestinal mucosal mass following resection. J Am Coll Nutr 1992; 11: 223-227.
127. Michail S, Mohammadpour H, Park JH, Vanderhoof JA. Effect of glutamine-supplemented elemental diet on mucosal adaptation following bowel resection in rats. J Pediatr Gastroenterol Nutr 1995; 21: 394-398.
128. Scolapio JS, McGreevy GS, Tennyson GS, Burnett OL. Effect of glutamine on intestinal function in short-bowel. Clin Nutr 2001; 20: 319-323.
129. Loran MR, Carbone JV. The humoral effect of intestinal resection on cellular proliferation and maturation in parabiotic rats. In: Sullivan MF, ed. Gastrointestinal radiation injury, Amsterdam: Excerpta Medica Foundation, 1968: 127-139.
130. Tilson MD, Livstone EM. Radioautography of heterotopic autografts of ileal mucosa in rats after partial enterectomy. Surg Forum 1975; 26: 393-394.
131. Dworkin LD, Levine GM, Farber NJ, Spector MH. Small intestinal mass of the rat is partially determined by indirect effects of intraluminal nutrition. Gastroenterology 1976; 71: 626-630.
132. Gleeson MH, Bloom SR, Polak JM, Henry K, Dowling RH. Endocrine tumour in kidney affecting small bowel structure, motility, and absorptive function. Gut 1971; 12: 773-782.
133. Stevens FM, Flanagan RW, O'Gorman D, Buchanan KD. Glucagonoma syndrome demonstrating giant duodenal villi. Gut 1984; 25: 784-791.
134. Unger RH, Eisentraut AM, Sims K, McCall MS, Madison LL. Site of origin of glucagon in dogs and humans. South Soc Clin Res 1961; 9: 53.
135. Andrews NJ, Irving MH. Human gut hormone profiles in patients with short bowel syndrome. Dig Dis Sci 1992; 37: 729-732.
136. Holst JJ, Sorensen TI, Andersen AN, et al. Plasma enteroglucagon after jejunoileal bypass with 3:1 or 1:3 jejunoileal ratio. Scand J Gastroenterol 1979; 14: 205-207.
137. Bloom SR. Hormonal changes after jejuno-ileal bypass and their physiological significance. In: Maxwell JD, Gazet JC, Pilkington TR, eds. Surgical management of obesity, London: Academic Press, 1980: 115-123.
138. Bloom SR, Besterman HS, Adrian TE, et al. Gut hormone profile following resection of large and small bowel. Gastroenterology 1979; 76: 1001.
139. Holst JJ. Evidence that glicentin contains the entire sequence of glucagon. Biochem J 1980; 187: 337-343.
140. Thim L, Moody AJ. The primary structure of porcine glicentin (proglucagon). Regul Pept 1981; 2: 139-150.
141. Drucker DJ, Erlich P, Asa SL, Brubaker PL. Induction of intestinal epithelial proliferation by glucagon-like peptide 2. Proc Natl Acad Sci USA 1996; 93: 7911-7916.
142. Tsai CH, Hill M, Drucker DJ. Biological determinants of intestinotrophic properties of GLP-2 in vivo. Am J Physiol 1997; 272: G662-8.
143. Tsai CH, Hill M, Asa SL, Brubaker PL, Drucker DJ. Intestinal growth-promoting properties of glucagon-like peptide-2 in mice. Am J Physiol 1997; 273: E77-84.
144. Orskov C, Holst JJ, Knuhtsen S, Baldissera FG, Poulsen SS, Nielsen OV. Glucagon-like peptides GLP-1 and GLP-2, predicted products of the glucagon gene, are secreted separately from pig small intestine but not pancreas. Endocrinology 1986; 119: 1467-1475.
145. Varndell IM, Bishop AE, Sikri KL, Uttenthal LO, Bloom SR, Polak JM. Localization of glucagon-like peptide (GLP) immunoreactants in human gut and pancreas using light and electron microscopic immunocytochemistry. J Histochem Cytochem 1985; 33: 1080-1086.
146. Larsson LI, Holst J, Hakanson R, Sundler F. Distribution and properties of glucagon immunoreactivity in the digestive tract of various mammals: an immunohistochemical and immunochemical study. Histochemistry 1975; 44: 281-290.
147. Holst JJ. Enteroglucagon. Annu Rev Physiol 1997; 59: 257-271.
148. Holst JJ, Orskov C, Nielsen OV, Schwartz TW. Truncated glucagon-like peptide 1, an insulin-releasing hormone from the distal gut. FEBS Lett 1987; 211: 169-174.
149. Mojsov S, Weir GC, Habener JF. Insulinotropin: glucagon-like peptide I(7-37) co-encoded in the glucagon gene is a potent stimulator of insulin release in the perfused rat pancreas. J Clin Invest 1987; 79: 616-619.
150. Holst JJ. Glucagonlike peptide 1: a newly discovered gastrointestinal hormone. Gastroenterology 1994; 107: 1848-1855.
151. Scott RB, Kirk D, MacNaughton WK, Meddings JB. GLP-2 augments the adaptive response to massive intestinal resection in rat. Am J Physiol 1998; 275: G911-21.
152. Thulesen J, Hartmann B, Kissow H, et al. Intestinal growth adaptation and circulating levels of glucagon-like peptide 2 (GLP-2) following small bowel resection and jejunoileal transposition in rats. Dig Dis Sci 2001; 46: 379-388.
153. Jeppesen PB, Hartmann B, Thulesen J, et al. Elevated plasma glucagon-like peptide 1 and 2 concentrations in ileum resected short bowel patients with a preserved colon. Gut 2000; 47: 370-376.
154. Jeppesen PB, Hartmann B, Hansen BS, Thulesen J, Holst JJ, Mortensen PB. Impaired meal stimulated glucagon-like peptide 2 response in ileal resected short bowel patients with intestinal failure [see comments]. Gut 1999; 45: 559-563.
155. Roberge JN, Brubaker PL. Regulation of intestinal proglucagon-derived peptide secretion by glucose-dependent insulinotropic peptide in a novel enteroendocrine loop. Endocrinology 1993; 133: 233-240.
156. Rocca AS, Brubaker PL. Role of the vagus nerve in mediating proximal nutrient-induced glucagon-like peptide-1 secretion. Endocrinology 1999; 140: 1687-1694.
157. Jeppesen PB. Betydningen af lipidernes fedtsyre-kædelængde for deres kliniske effekt i den enterale og parenterale ernæring af tarmsyge patienter [The significance of fatty acid chain lenght of lipids for their clinical effect in the enteral and parenteral nutrition of patients with intestinal diseases]. Ph.D.-thesis, The Faculty of Health Sciences, University of Copenhagen 1998; 1-92.
158. Englyst HN, Cummings JH. Non-starch polysaccharides (dietary fiber) and resistant starch. Adv Exp Med Biol 1990; 270: 205-225.
159. AOAC official methods of analysis. Arlington: AOAC Inc. 1984.
160. Jeppesen PB, Mortensen PB. Intestinal failure defined by measurements of intestinal energy and wet weight absorption. Gut 2000; 46: 701-706.
161. Vaisman N, Rossi MF, Goldberg E, Dibden LJ, Wykes LJ, Pencharz PB. Energy expenditure and body composition in patients with anorexia nervosa. J Pediatr 1988; 113: 919-924.
162. Schebendach JE, Golden NH, Jacobson MS, Hertz S, Shenker IR. The metabolic responses to starvation and refeeding in adolescents with anorexia nervosa. Ann N Y Acad Sci 1997; 817: 110-119.
163. Krahn DD, Rock C, Dechert RE, Naim KK, Hasse SA. Changes in resting energy expenditure and body composition in anorexia nervosa patients during refeeding [see comments]. J Am Diet Assoc 1993; 93: 434-438.
164. Rodrigues CA, Lennard Jones JE, Thompson DG, Farthing MJ. Energy absorption as a measure of intestinal failure in the short bowel syndrome. Gut 1989; 30: 176-183.
165. Messing B, Pigot F, Rongier M, Morin MC, Ndeindoum U, Rambaud JC. Intestinal absorption of free oral hyperalimentation in the very short bowel syndrome. Gastroenterology 1991; 100: 1502-1508.
166. Siguel EN, Maclure M. Relative activity of unsaturated fatty acid metabolic pathways in humans. Metabolism 1987; 36: 664-669.
167. Mead JF. The non-eicosanoid functions of the essential fatty acids. J Lipid Res 1984; 25: 1517-1521.
168. Spector AA, Yorek MA. Membrane lipid composition and cellular function. J Lipid Res 1985; 26: 1015-1035.
169. Falardeau P, Hamberg M, Samuelsson B. Metabolism of 8,11,14-eicosatrienoic acid in human platelets. Biochim Biophys Acta 1976; 441: 193-200.
170. Samuelsson B. Leukotrienes: mediators of immediate hypersensitivity reactions and inflammation. Science 1983; 220: 568-75.
171. Samuelsson B, Goldyne M, Granstrom E, Hamberg M, Hammarstrom S, Malmsten C. Prostaglandins and thromboxanes. Annu Rev Biochem 1978; 47:997-1029.
172. Rask-Madsen J. Eicosanoids in inflammatory bowel disease: advances, pitfalls and therapeutic consequences. Eur J Gastroenterol Hepatol 1989; 1: 133-165.
173. Lee TH, Hoover RL, Williams JD, et al. Effect of dietary enrichment with eicosapentaenoic and docosahexaenoic acids on in vitro neutrophil and monocyte leukotriene generation and neutrophil function. N Engl J Med 1985; 312: 1217-1224.
174. Lorenz R, Weber PC, Szimnau P, Heldwein W, Strasser T, Loeschke K. Supplementation with n-3 fatty acids from fish oil in chronic inflammatory bowel disease - a randomized, placebo-controlled, double-blind cross-over trial. J Intern Med Suppl 1989; 225: 225-232.
175. Holman RT, Smythe L, Johnson S. Effect of sex and age on fatty acid composition of human serum lipids. Am J Clin Nutr 1979; 32: 2390-2399.
176. Hansen AE, Wiese HF, Boelsche AN, Haggard ME, Adam DJD, Davis H. Role of linoleic acid in infant nutrition. Pediatrics 1963; 31: 171-192.
177. Hansen HS, Jensen B. Essential function of linoleic acid esterified in acylglucosylceramide and acylceramide in maintaining the epidermal water permeability barrier. Biochim Biophys Acta 1985; 834: 357-383.
178. MacMillan AL, Sinclair HM. Sinclair HM, ed. Essential Fatty Acids. London: Butterworth, 1958: 208-215.
179. Cederholm TE, Berg AB, Johansson EK, Hellstrom KH, Palmblad JE. Low levels of essential fatty acids are related to impaired delayed skin hypersensitivity in malnourished chronically ill elderly people. Eur J Clin Invest 1994; 24: 615-620.
180. Hulsey TK, Burnham SJ, Neblett WW, O'Neill JA, Jr., Meng HC. Delayed burn wound healing in essential fatty acid deficiency. Surg Forum 1977; 28: 31-32.
181. Vergroesen AJ. Early signs of polyunsaturated fatty acid deficiency. Bibl Nutr Dieta 1976; 23: 19-26.
182. Sinclair AJ, Collins FD. Fatty livers in rats deficient in essential fatty acids. Biochim Biophys Acta 1968; 152: 498-510.
183. Clark SB, Ekkers TE, Singh A, Balint JA, Holt PR, Rodgers JB, Jr. Fat absorption in essential fatty acid deficiency: a model experimental approach to studies of the mechanism of fat malabsorption of unknown etiology. J Lipid Res 1973; 14: 581-588.
184. Richardson TJ, Sgoutas D. Essential fatty acid deficiency in four adult patients during total parenteral nutrition. Am J Clin Nutr 1975; 28: 258-263.
185. Goodgame JT, Lowry SF, Brennan MF. Essential fatty acid deficiency in total parenteral nutrition: time course of development and suggestions for therapy. Surgery 1978; 84: 271-277.
186. Tanphaichitr V, Tanchurat N, Viriyapanich T, Komindr S. Essential fatty acid status in Thai patients receiving total parenteral nutrition. JPEN J Parenter Enteral Nutr 1979; 3: 164-168.
187. Stein TP, Buzby GP, Hargrove WC, 3d, Leskiw MJ, Mullen JL. Essential fatty acid deficiency in patients receiving simultaneous parenteral and oral nutrition. JPEN J Parenter Enteral Nutr 1980; 4: 343-345.
188. Hansen AE, Wiese HF. Essential fatty acids and human nutrition. II. Serum level for unsaturated fatty acids in poorly nourished infants and children. J Nutr 1954; 367-374.
189. Shimoyama T, Kikuchi H, Press M, Thompson GR. Fatty acid composition of plasma lipoproteins in control subjects and in patients with malabsorption. Gut 1973; 14: 716-722.
190. Färkkilä MA, Tilvis RS, Miettinen TA. Plasma fatty acid composition in patients with ileal dysfunction. Scand J Gastroenterol 1987; 22: 411-419.
191. Wapnick S, Norden DA, Venturas DJ. Essential fatty acid deficiency in patients with lesions of the gastrointestinal tract. Gut 1974; 367-370.
192. Siguel EN, Chee KM, Gong JX, Schaefer EJ. Criteria for essential fatty acid deficiency in plasma as assessed by capillary column gas-liquid
193. Kuo PT, Huang NN. The effect of medium chain triglyceride upon fat absorption and plasma lipid and depot fat of children with cystic fibrosis of the pancreas. J Clin Invest 1965; 44: 1924-1933.
194. Caren R, Corbo L. Plasma fatty acids in pancreatic cystic fibrosis and liver disease. J Clin Endocrinol Metab 1966; 26: 470-477.
195. Rey J, Frezal J, Polonovski J, Lamy M. Modifications des lipides plasmatiques dans les troubles de l'absorption intestinale chez l'enfant. Rev franc Étud clin biol 1965; 10: 488-494.
196. Jeppesen PB, Christensen MS, Høy CE, Mortensen PB. Essential fatty acid deficiency in patients with severe fat malabsorption. Am J Clin Nutr 1997; 65: 837-843.
197. FAO. Fats and oils in human nutrition. Report of a joint expert consultation. Rome: World Health Organization, 1993.
198. Riella MC, Broviac JW, Wells M, Scribner BH. Essential fatty acid deficiency in human adults during total parenteral nutrition. Ann Intern Med 1975; 83: 786-789.
199. Stegink LD, Freeman JB, Wispe J, Connor WE. Absence of the biochemical symptoms of essential fatty acid deficiency in surgical patients undergoing protein sparing therapy. Am J Clin Nutr 1977; 30: 388-393.
200. Abushufa R, Reed P, Weinkove C, Wales S, Shaffer J. Essential fatty acid status in patients on long-term home parenteral nutrition. JPEN J Parenter Enteral Nutr 1995; 19: 286-290.
201. Postuma R, Pease PW, Watts R, Taylor S, McEvoy FA. Essential fatty acid deficiency in infants receiving parenteral nutrition. J Pediatr Surg 1978; 13: 393-398.
202. Jeppesen PB, Høy CE, Mortensen PB. Essential fatty acid deficiency in patients receiving home parenteral nutrition. Am J Clin Nutr 1998; 68: 126-133.
203. Jeppesen PB, Høy CE, Mortensen PB. Deficiencies of essential fatty acids, vitamin A and E and changes in plasma lipoproteins in patients with reduced fat absorption or intestinal failure. Eur J Clin Nutr 2000; 54: 632-642.
204. Mascioli EA, Lopes SM, Champagne C, Driscoll DF. Essential fatty acid deficiency and home total parenteral nutrition patients. Nutrition 1996; 12: 245-249.
205. Jeppesen PB, Høy CE, Mortensen PB. Differences in essential fatty acid requirements by enteral and parenteral routes of administration in patients with fat malabsorption. Am J Clin Nutr 1999; 70: 78-84.
206. Jeejeebhoy KN. Does twice a week lipid infusion prevent essential fatty acid (EFA) deficiency during total parenteral nutrition (TPN) [editorial]. Nutrition 1990; 6: 193
207. Wilmore DW, Dudrick SJ. Growth and development of an infant receiving all nutrients exclusively by vein. JAMA 1968; 203: 860-864.
208. Grant D. Current results of intestinal transplantation. The International Intestinal Transplant Registry. Lancet 1996; 347: 1801-1803.
209. Jeppesen PB, Staun M, Mortensen PB. Adult patients receiving home parenteral nutrition in Denmark from 1991 to 1996: who will benefit from intestinal transplantation? Scand J Gastroenterol 1998; 33: 839-846.
210. Howard L, Ament M, Fleming CR, Shike M, Steiger E. Current use and clinical outcome of home parenteral and enteral nutrition therapies in the United States. Gastroenterology 1995; 109: 355-365.
211. Howard L, Malone M. Current status of home parenteral nutrition in the United States. Transplant Proc 1996; 28: 2691-2695.
212. Van Gossum A, Bakker H, De Francesco A, et al. Home parenteral nutrition in adults: a multicentre survey in Europe in 1993. Clinical Nutrition 1996; 15: 53-59.
213. Bakker H, Bozzetti F, Staun M, et al. Home parenteral nutrition in adults: a european multicentre survey in 1997. ESPEN-Home Artificial Nutrition Working Group [see comments]. Clin Nutr 1999; 18: 135-140.
214. Abu-Elmagd K, Todo S, Tsakis A, et al. Three years clinical experience with intestinal transplantation. J Am Coll Surg 1994; 179: 385-400.
215. Brousse N, Goulet O. Small bowel transplantation [editorial]. BMJ 1996; 312: 261-262.
216. Asfar S, Atkison P, Ghent C, et al. Small bowel transplantation. A lifesaving option for selected patients with intestinal failure. Dig Dis Sci 1996; 41: 875-883.
217. Scolapio JS, Fleming CR, Kelly DG, Wick DM, Zinsmeister AR. Survival of home parenteral nutrition-treated patients: 20 years of experience at the Mayo Clinic. Mayo Clin Proc 1999; 74: 217-222.
218. Messing B, Lemann M, Landais P, et al. Prognosis of patients with nonmalignant chronic intestinal failure receiving long-term home parenteral nutrition [see comments]. Gastroenterology 1995; 108: 1005-1010.
219. Detsky AS, McLaughlin JR, Abrams HB, et al. Quality of life of patients on long-term total parenteral nutrition at home. J Gen Intern Med 1986; 1: 26-33.
220. Robinovitch AE. Home total parenteral nutrition: a psycho-social viewpoint. JPEN J Parenter Enteral Nutr 1981; 5: 522-525.
221. Jeppesen PB, Langholz E, Mortensen PB. Quality of life in patients receiving home parenteral nutrition. Gut 1999; 44: 844-852.
222. Bergner M, Bobbitt RA, Carter WB, Gilson BS. The Sickness Impact Profile: development and final revision of a health status measure. Med Care 1981; 19: 787-805.
223. Guyatt G, Mitchell A, Irvine EJ, et al. A new measure of health status for clinical trials in inflammatory bowel disease. Gastroenterology 1989; 96: 804-810.
224. Laupacis A, Keown P, Pus N, et al. A study of the quality of life and cost-utility of renal transplantation. Kidney Int 1996; 50: 235-242.
225. Nightingale JM. The Sir David Cuthbertson Medal Lecture. Clinical problems of a short bowel and their treatment. Proc Nutr Soc 1994; 53: 373-391.
226. Richards DM, Irving MH. Assessing the quality of life of patients with intestinal failure on home parenteral nutrition. Gut 1997; 40: 218-222.
227. Messing B, Landais P, Goldfarb B, Irving M. Home Parenteral Nutrition in Adults: a Multicentre Survey in Europe. Clin Nutr 1989; 8: 3-9.
228. Price BS, Levine EL. Permanent total parenteral nutrition: psychological and social responses of the early stages. JPEN J Parenter Enteral Nutr 1979; 3: 48-52.
229. Levy NB, Wynbrandt GD. The quality of life on maintenance haemodialysis. Lancet 1975; 1: 1328
230. Carlson GL, Maguire G, Williams N, Bradley A, Schaffer J, Irving MH. Quality of life on home parenteral nutrition and attitudes towards intestinal transplantation. A single centre study of 37 patients. Clin Nutr 1998; Submitted.
231. DiMartini A, Rovera GM, Graham TO, et al. Quality of life after small intestinal transplantation and among home parenteral nutrition patients. JPEN J Parenter Enteral Nutr 1998; 22: 357-362.
232. Cummings JH, James WP, Wiggins HS. Role of the colon in ileal-resection diarrhoea. Lancet 1973; 1: 344-347.
233. Kellock TD, Pearson JR, Russell RI, Walker JG, Wiggins HS. The incidence and clinical significance of faecal hydroxy fatty acids. Gut 1969; 10: 1055
234. Andersson H. The use of a low-fat diet in the symptomatic treatment of ileopathia. World Rev Nutr Diet 1982; 40: 1-18.
235. Hessov I, Andersson H, Isaksson B. Effects of a low-fat diet on mineral absorption in small-bowel disease. Scand J Gastroenterol 1983; 18: 551-554.
236. Bond JH, Currier BE, Buchwald H, Levitt MD. Colonic conservation of malabsorbed carbohydrate. Gastroenterology 1980; 78: 444-447.
237. Royall D, Wolever TM, Jeejeebhoy KN. Evidence for colonic conservation of malabsorbed carbohydrate in short bowel syndrome. Am J Gastroenterol 1992; 87: 751-756.
238. Royall D, Wolever TM, Jeejeebhoy KN. Clinical significance of colonic fermentation. Am J Gastroenterol 1990; 85: 1307-1312.
239. Jeppesen PB, Mortensen PB. Significance of a preserved colon for parenteral energy requirements in patients receiving home parenteral nutrition. Scand J Gastroenterol 1998; 33: 1175-1179.
240. Bach AC, Babayan VK. Medium-chain triglycerides: an update. Am J Clin Nutr 1982; 36: 950-962.
241. Valdivieso V. Absorption of medium-chain triglycerides in animals with pancreatic atrophy. Am J Dig Dis 1972; 17: 129-137.
242. Bochenek W, Rodgers JB, Jr., Balint JA. Effects of changes in dietary lipids on intestinal fluid loss in the short-bowel syndrome. Ann Intern Med 1970; 72: 205-213.
243. Zurier RB, Campbell RG, Hashim SA, Van Itallie TB. Use of medium-chain triglyceride in management of patients with massive resection of the small intestine. N Engl J Med 1966; 274: 490-493.
244. Tandon RK, Rodgers JB, Jr., Balint JA. The effects of medium-chain triglycerides in the short bowel syndrome. Increased glucose and water transport. Am J Dig Dis 1972; 17: 233-238.
245. Pihl BG, Glotzer DJ, Patterson JF. Absorption of medium-chain fatty acids by the dog colon. J Appl Physiol 1966; 21: 1059-1062.
246. Valdivieso VD, Schwabe AD. Absorption of medium-chain lipids from the rat cecum. Am J Dig Dis 1966; 11: 474-479.
247. Jorgensen J, Holtug K, Jeppesen PB, Mortensen PB. Human rectal absorption of short- and medium-chain C2-C 10 fatty acids. Scand J Gastroenterol 1998; 33: 590-594.
248. Linscheer WG, Castell DO, Platt RR. A new method for evaluation of portasystemic shunting. The rectal octanoate tolerance test. Gastroenterology 1969; 57: 415-423.
249. Jeppesen PB, Mortensen PB. The influence of a preserved colon on the absorption of medium chain fat in patients with small bowel resection. Gut 1998; 43: 478-483.
250. Jorgensen JR, Fitch MD, Mortensen PB, Fleming SE. In vivo absorption of medium-chain fatty acids by the rat colon exceeds that of short-chain fatty acids. Gastroenterology 2001; 120: 1152-1161.
251. Borgström B. Studies on intestinal cholesterol absorption in the human. J Clin Invest 1960; 39: 809-815.
252. Hofmann AF, Borgström B. The intraluminal phase of fat digestion in man: The lipid content of the micellar and oil phases of intestinal content obtained during fat digestion and absorption. J Clin Invest 1964; 43: 247-257.
253. Simko V, McCarroll AM, Goodman S, Weesner RE, Kelley RE. High-fat diet in a short bowel syndrome. Intestinal absorption and gastroenteropancreatic hormone responses. Dig Dis Sci 1980; 25: 333-339.
254. McIntyre PB, Fitchew M, Lennard Jones JE. Patients with a high-jejunostomy do not need a special diet. Gastroenterology 1986; 91: 25-33.
255. Woolf GM, Miller C, Kurian R, Jeejeebhoy KN. Diet for patients with a short bowel: high fat or high carbohydrate? Gastroenterology 1983; 84: 823-828.
256. Ovesen L, Chu R, Howard L. The influence of dietary fat on jejunostomy output in patients with severe short bowel syndrome. Am J Clin Nutr 1983; 38: 270-277.
257. Fordtran JS. Stimulation of active and passive sodium absorption by sugars in the human jejunum. J Clin Invest 1975; 55: 728-737.
258. Sladen GE, Dawson AM. Interrelationships between the absorptions of glucose, sodium and water by the normal human jejunum. Clin Sci 1969; 36: 119-132.
259. Newton CR, Gonvers JJ, McIntyre PB, Preston DM, Lennard Jones JE. Effect of different drinks on fluid and electrolyte losses from a jejunostomy. J R Soc Med 1985; 78: 27-34.
260. Rodrigues CA, Lennard Jones JE, Thompson DG, Farthing MJ. What is the ideal sodium concentration of oral rehydration solutions for short bowel patients? Clin Sci 1988; 74: 69.
261. Nightingale JM, Lennard Jones JE, Walker ER, Farthing MJ. Oral salt supplements to compensate for jejunostomy losses: comparison of sodium chloride capsules, glucose electrolyte solution, and glucose polymer electrolyte solution. Gut 1992; 33: 759-761.
262. Cortot A, Fleming CR, Malagelada JR. Improved nutrient absorption after cimetidine in short-bowel syndrome with gastric hypersecretion. N Engl J Med 1979; 300: 79-80.
263. Doherty NJ, Sufian S, Pavlides CA, Matsumoto T. Cimetidine in the treatment of severe metabolic alkalosis secondary to short bowel syndrome. Int Surg 1978; 63: 140-142.
264. Nightingale JM, Walker ER, Farthing MJ, Lennard Jones JE. Effect of omeprazole on intestinal output in the short bowel syndrome. Aliment Pharmacol Ther 1991; 5: 405-412.
265. 2-receptor blocking agent on diarrhoeas after extensive small bowel resection in Crohn's disease. Acta Med Scand 1980; 207: 119-122.
266. Jacobsen O, Ladefoged K, Stage JG, Jarnum S. Effects of cimetidine on jejunostomy effluents in patients with severe short-bowel syndrome. Scand J Gastroenterol 1986; 21: 824-828.
267. Jeppesen PB, Staun M, Tjellesen L, Mortensen PB. Effect of intravenous ranitidine and omeprazole on intestinal absorption of water, sodium, and macronutrients in patients with intestinal resection. Gut 1998; 43: 763-769.
268. Reichlin S. Somatostatin. N Engl J Med 1983; 309: 1495-1501.
269. Bloom SR, Mortimer CH, Thorner MO, et al. Inhibition of gastrin and gastric-acid secretion by growth-hormone release-inhibiting hormone. Lancet 1974; 2: 1106-1109.
270. Kayasseh L, Gyr K, Stalder GA, Rittmann WW, Girard J. Effect of somatostatin on exocrine pancreatic secretion stimulated by pancreozymin-secretin or by a test meal in the dog. Horm Res 1978; 9: 176-184.
271. Meyers WC, Hanks JB, Jones RS. Inhibition of basal and meal-stimulated choleresis by somatostatin. Surgery 1979; 86: 301-306.
272. O'Keefe SJ, Haymond MW, Bennet WM, Oswald B, Nelson DK, Shorter RG. Long-acting somatostatin analogue therapy and protein metabolism in patients with jejunostomies. Gastroenterology 1994; 107: 379-388.
273. O'Keefe SJ, Peterson ME, Fleming CR. Octreotide as an adjunct to home parenteral nutrition in the management of permanent end-jejunostomy syndrome. JPEN J Parenter Enteral Nutr 1994; 18: 26-34.
274. Nightingale JM, Walker ER, Burnham WR, Farthing MJ, Lennard Jones JE. Octreotide (a somatostatin analogue) improves the quality of life in some patients with a short intestine. Aliment Pharmacol Ther 1989; 3: 367-373.
275. Ladefoged K, Christensen KC, Hegnhoj J, Jamum S. Effect of a long acting somatostatin analogue SMS 201-995 on jejunostomy effluents in patients with severe short bowel syndrome [see comments]. Gut 1989; 30: 943-949.
276. King RF, Norton T, Hill GL. A double-blind crossover study of the effect of loperamide hydrochloride and codeine phosphate on ileostomy output. Aust N Z J Surg 1982; 52: 121-124.
277. Rodrigues CA, Lennard Jones JE, Thompson DG, Farthing MJ. The effects of octreotide, soy polysaccharide, codeine and loperamide on nutrient, fluid and electrolyte absorption in the short-bowel syndrome. Aliment Pharmacol Ther 1989; 3: 159-169.
278. Byrne TA, Morrissey TB, Nattakom TV, Ziegler TR, Wilmore DW. Growth hormone, glutamine, and a modified diet enhance nutrient absorption in patients with severe short bowel syndrome. JPEN J Parenter Enteral Nutr 1995; 19: 296-302.
279. Byrne TA, Persinger RL, Young LS, Ziegler TR, Wilmore DW. A new treatment for patients with short-bowel syndrome. Growth hormone, glutamine, and a modified diet. Ann Surg 1995; 222: 243-254.
280. Ellegård L, Bosaeus I, Nordgren S, Bengtsson BA. Low-dose recombinant human growth hormone increases body weight and lean body mass in patients with short bowel syndrome. Ann Surg 1997; 225: 88-96.
281. Scolapio JS, Camilleri M, Fleming CR, et al. Effect of growth hormone, glutamine, and diet on adaptation in short-bowel syndrome: A randomized, controlled study. Gastroenterology 1997; 113: 1074-1081.
282. Scolapio JS. Effect of growth hormone, glutamine, and diet on body composition in short bowel syndrome: a randomized, controlled study. JPEN J Parenter Enteral Nutr 1999; 23: 309-313.
283. Szkudlarek J, Jeppesen PB, Mortensen PB. Effect of high dose growth hormone with glutamine and no change in diet on intestinal absorption in short bowel patients: a randomised, double blind, crossover, placebo controlled study. Gut 2000; 47: 199-205.
284. Jeppesen PB, Szkudlarek J, Høy C-E, Mortensen PB. Effect of high dose growth hormone and glutamine on body composition, urine creatinine excretion, fatty acid absorption, and essential fatty acid status in short bowel patients. A randomised, double blind, cross-over, placebo-controlled study. Scand J Gastroenterol 2001; 36: 48-54.
285. Seguy D, Vahedi K, Crenn P, et al. Growth hormone benefit in very short bowel patients: a randomized trial. Clin Nutr 1999; 18: 13-A51.
286. Brevinge H, Berglund B, Bosaeus I, Tolli J, Nordgren S, Lundholm K. Exercise capacity in patients undergoing proctocolectomy and small bowel resection for Crohn's disease. Br J Surg 1995; 82: 1040-1045.
287. Heymsfield SB, Arteaga C, McManus C, Smith J, Moffitt S. Measurement of muscle mass in humans: validity of the 24-hour urinary creatinine method. Am J Clin Nutr 1983; 37: 478-494.
288. Pietrobelli A, Wang Z, Formica C, Heymsfield SB. Dual-energy X-ray absorptiometry: fat estimation errors due to variation in soft tissue hydration. Am J Physiol 1998; 274: E808-16.
289. Fuller NJ, Jebb SA, Laskey MA, Coward WA, Elia M. Four-component model for the assessment of body composition in humans: comparison with alternative methods, and evaluation of the density and hydration of fat-free mass. Clin Sci Colch 1992; 82: 687-693.
290. Heymsfield SB, Wang Z, Baumgartner RN, Ross R. Human body composition: advances in models and methods. Annu Rev Nutr 1997; 17: 527-558.
291. Byrne T, Wilmore D. Does growth hormone and glutamine enhance bowel absorption? [letter]. Gastroenterology 1998; 114: 1110-1112.
292. Rubin DC. Nutrient regulation of intestinal growth and adaptation: role of glucagon-like peptide 2 and the enteroendocrine cell [editorial; comment]. Gastroenterology 1999; 117: 261-263.
293. Nightingale JM. Short bowel, short answer? Gut 1999; 45: 478-479.
294. Jeppesen PB, Hartmann B, Thulesen J, et al. Glucagon-like peptide-2 (GLP-2) improves nutrient absorption and nutritional status in short bowel patients with no colon. Gastroenterology 2001; 120: 806-815.
295. Drucker DJ, Shi Q, Crivici A, et al. Regulation of the biological activity of glucagon-like peptide 2 in vivo by dipeptidyl peptidase IV. Nat Biotechnol 1997; 15: 673-677.